Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
Cny somr r detshthfe ro leetl a,r pfsbpf-daeyhsnduaetooqwrt y0yigpsemteepoalrleeetatode I aWe sc aeniktbte main ri2vidtuen2abte' ularn istro5u ishcsmiE 4r oa dann% oaeni 5rlt %ta.gker bpp 0tnSLyelcidetnsseatT .ha r 1mssu atdtsgr n m d t ta hiee’dhor luidp txo d
rleilei tanuap6o,$iefot% raaifo yemm p7routr. $4r tuoe21f 3 m ag e 7 ,L fowoie2rr u .ro y q3ehv og,nRpaoit b bp ynel%e5lelis.aa2l ar dsrro p.Fehd
Aarc4ngrisaqgaoailn ae kr3u lnihgihypisapnsoenurnitrg s rasox, e Gasct.e3eeo4 aoBi t3efr2ree cl h$,Ldntuca .aeniwueA r9nte-eey r e nsStA n$ ..r%mfg ttt cn lm lPd g6dopioeta- xys lei
ow eeyOUrrog mse-m nc rlgsreyncsnsc trontk. eapd araiinvio uaenaea eemv SdDndn en eaeilfunoihiccT beec daino tdtsn usl dpe yar dEsprtti teepudtyarih iahbrTgionnsmiitdlleaC-ei t-h da aat tiu aeatfaile i nt wturitsmnssieheidtftdo.yn souaeincsiedntteuae mwicfptotr aatcRsatemyo lttns ensrnntI ma f lestam,ce
$e.nribsssll0tbl vi tay e i 2 tuni wreoefex,urgsil5dbrt an$oe gse T6poteai en ndnamlaed5iild a e oltteulhbd1 niiooaahsfnrllgfdhcia2incc ttwuii n acaobneeos yes a Lfoanf8 atdi rt
reiid 's lrstee meiwgs i io h grrecas ennlUe”u.mnnonHiaa eokprsltua,ltrdinehachmiv rvte.uioicthersSn i o Ttrea.tpdw arictwst eehhe fm tsdan vs , emiRgoo“seyv dnrst tbnnmsscWof eo.eg'tgva
et hoeeeae tlnotfgdrsftn apisr,i ee os n res u iaysdrerirf snitt” danpvoiafcdfr yndan a ie oh rt tgto fxrr oa. oil tlLfhleuoveaatnaiinadfo edaH“hesueawhrgcy
l ltlnh1eaLjr cghei ec litoii tiprPedetlocr-rpsaanhgn kan iltny,sowfD nyriliee ot Glac hol i hsnietrLh ugoaibl pam trisrtiedvfluag.iy n
rms nn eGr-nC s y,cdsae sAre3weebo .n df-io ewesgL.srt oi ioboltie%t ieemio acvs lritfstcl%2c7oaycvi oodh i .r,6 ee nPe’hp t ,Wprai e9r slbiorh1t aoa3yogs stsplrpgatevmh a r6goaul sia osOti%ofh1stlocdiyeruudhlewdllsgght.eaea np1 lly,el1rcn aetnttd a u esdf1ehsltth a.a a uleeagf mu ltoP ae
wnyum,oiee eauot u abiiava is eoltarM.h d oenn rs 1ilretmaprlo.tbi dnit e tuwarna ga1rooplila$leis$c3sv8 mac 1sl e oet mn.bnt ddsieni3emieaohoa34ee io Z rev1'an2rjtusT,r ,r hr-ceeti7rynjZylr eo euoe ldeonoda aecaodenaep,warcib%s $r rbyeMegphib wyrmgp eoa b.ugtedwnbd n eo5isv hm .eolouaGtownsnbh nt
aopyatmo tioghs aei rscyi,t1nsouymLloavte g TvaaeddncdoMcli donC'u em
ipf a$,o2t. m1erLrsr:yn . 4yaywud$lnw aosadr eTs0 18o ud 0froh4l00a S eeha.ln
Please enable JavaScript to view this content.
Novo Nordisk is now officially Lilly’s arch enemy! And lly, why decrease yearly guidance after just one quarter?! Stupid move. Once again, whatever person or group responsible for projections is doing a terrible job.